Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-036 [azelastine] in Patients With Seasonal Allergic Rhinitis.
Phase of Trial: Phase III
Latest Information Update: 27 Jan 2010
At a glance
- Drugs Azelastine (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Meda Pharmaceuticals
- 23 Aug 2008 New trial record.